You are here

  • Home
  • Archive
  • Volume 70, Issue 11
  • Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway

Article info

Article menu
Download PDFPDF
Basic and translational research
Extended report
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway

Authors

  1. Correspondence to Dr Brandon W Higgs, Translational Sciences, MedImmune, One MedImmune Way, Gaithersburg, MD 20878, USA; higgsb{at}medimmune.com or Dr Yihong Yao, Translational Sciences, MedImmune LLC, One MedImmune Way, Gaithersburg, MD 20878, USA; yaoy{at}medimmune.com
View Full Text

Citation

Higgs BW, Liu Z, White B, et al
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway
Annals of the Rheumatic Diseases 2011;70:2029-2036.

Publication history

  • Accepted June 13, 2011
  • First published July 28, 2011.
Online issue publication 
January 10, 2024

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions